$ASTS

AST SpaceMobile Soars 12% on Berenberg’s $92 Price Target, Planet Labs Climbs 5%

AST SpaceMobile (ASTS) and Planet Labs (PL) rose 12% and 5% respectively, following Berenberg's initiation with $92 and $25 price targets. Analyst Michael Filatov cited unique positions in space. ASTS is up 11% to $62.36, PL up 5% to $20.14. Planet Labs reports earnings September 3.

Original reporting
Published Sep 2, 2026, 2:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 3:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AST SpaceMobile Soars 12% on Berenberg’s $92 Price Target, Planet Labs Climbs 5% — source image
Decision brief

The 30-second read

$ASTSBullishMed
01

Why it matters

The initiations sparked immediate price gains, suggesting short‑term momentum but longer‑term performance hinges on operational milestones.

02

Market read

Provides fresh analyst coverage and price targets for three space‑tech stocks, creating short‑term trading opportunities.

03

What to watch

Potential regulatory hurdles and competition from larger players like SpaceX could temper upside.

Relevance 7/10Novelty 6/10Timing: today pre‑market

Background

Analyst Berenberg launched a new space sector coverage, initiating three stocks with aggressive price targets.

Company-level read

Ticker impact

$ASTSBullishHigh confidence
Context

Berenberg initiated ASTS at Buy with a $92 price target, driving a 12% intraday rise.

Expected impact

Potential continued rally if target holds, watch for follow‑through on launch milestones.

Evidence & confidence

Strong analyst thesis and recent satellite launches provide catalyst.

$PLBullishMedium confidence
Context

Berenberg initiated Planet Labs at Buy with a $25 price target, lifting the stock 5% intraday.

Expected impact

Likely modest upside; monitor earnings release for confirmation.

Evidence & confidence

Backlog expansion cited, but earnings still pending.

$RKLBBullishMedium confidence
Context

Berenberg also initiated Rocket Lab at Buy with an $83 target, contributing to sector‑wide bounce.

Expected impact

Potential modest gain; watch for launch schedule updates.

Evidence & confidence

Same analyst thesis, but less price movement reported.

Market effects

Highlights renewed investor interest in space‑tech equities.

U.S. small‑cap space sector may see broader buying.

Limited to investors tracking space infrastructure and satellite services.

Counterpoint

Price targets may be overly optimistic given execution risk of satellite constellations.

Key entities

  • Michael Filatov

    Berenberg analyst who initiated the coverage.

  • SpaceX

    Provided Falcon 9 launch services for ASTS satellites.

Related articles

$ASTSHigh

Why is AST SpaceMobile stock surging today?

AST SpaceMobile (ASTS) stock rose 8.1% after Berenberg initiated coverage with a Buy rating and $92 price target, citing its unique satellite connectivity tech and 60+ mobile network partnerships. The company expects commercial service to scale in 2027. The broader market had minimal impact on ASTS's move.

$RKLBMed

Berenberg launches space coverage, initiates 4 stocks with Buy ratings

Berenberg initiated coverage of the space sector, rating Rocket Lab, AST SpaceMobile, Planet Labs, and HawkEye 360 as Buy, and Avio SpA as Hold. Analyst Michael Filatov expects the space economy to exceed $1 trillion by 2030, driven by falling launch costs and defense spending. Price targets were set at $83 for Rocket Lab, $92 for AST SpaceMobile, $25 for Planet Labs, and $24 for HawkEye 360, while Avio SpA was given a €33 target.

$RKLBMedAI 8/10

Cathie Wood Makes Surprise $51 Million Bet on 2 Growth Stocks

ARK Invest, led by Cathie Wood, purchased $38.1 million of Block (XYZ) and $12.8 million of Rocket Lab (RKLB) shares, trimming positions in Palantir (PLTR), Shopify (SHOP), and AMD (AMD). Block reported Q2 gross profit growth of 25% and raised its 2026 forecast. Rocket Lab saw Q2 revenue rise 62% but still posted a loss.

$RKLBMed

Rocket Lab Keeps Faltering So Why Does One Big Bank Currently Expect 100% Upside?

Rocket Lab (RKLB) shares are down 57% from their 52-week high, despite a 137% increase in backlog to $2.36 billion. KeyBanc set a $135 target, implying 111% upside, citing Rocket Lab's position as a SpaceX challenger and high conviction in Neutron scaling. The company's Q2 revenue grew 62% YoY, but GAAP EPS missed estimates due to acquisition costs. Analysts remain bullish, with 14 Buy ratings and 4 Holds.

$RKLBMedAI 8/10

NZ halves time to launch rockets in space goldrush

New Zealand has reduced rocket launch approval times from 11 to 5 weeks to boost its aerospace industry. Rocket Lab, a US-listed NZ-founded company, is a key player, with the government seeking to double industry size. The Space Agency is consulting on further streamlining regulations, with Rocket Lab's input. Global space demand is rising, driven by commercial and defense needs. Rocket Lab, with a $70B market cap, is expanding but faces limitations in NZ for its Neutron rocket.

$RKLBMedAI 8/10

RKLB Stock Heads For Third Weekly Loss After 7 Bruising Sessions: SpaceX Raises Red Flag Over Iridium Deal

Rocket Lab (RKLB) shares are set for a third weekly loss amid a spectrum dispute between SpaceX (SPCE) and Iridium (IRDM) over RKLB's $8.1B acquisition of IRDM. SpaceX raised concerns with the FCC, while RKLB stock rose 2% on Thursday. The merger, valued at $6B in equity, awaits a shareholder vote on Sept. 24. RKLB also reported progress on its Neutron rocket.